Photo by nci from unsplash
Antithrombin deficiency is a strong risk factor for venous thromboembolism (VTE) whose testing has demonstrated usefulness.[1][1]–[5][2] Most cases of antithrombin deficiency are explained by mutations in SERPINC1 , the gene… Click to show full abstract
Antithrombin deficiency is a strong risk factor for venous thromboembolism (VTE) whose testing has demonstrated usefulness.[1][1]–[5][2] Most cases of antithrombin deficiency are explained by mutations in SERPINC1 , the gene encoding this anticoagulant, with detection rate ranging from 70–80%.[6
Keywords:
transient hypoglycosylation;
mpi cdg;
hypoglycosylation antithrombin;
antithrombin deficiency;
cdg transient;
deficiency
Journal Title: Haematologica
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Haematologica
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!